Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin αvβ3 and medical use thereof
US7037666B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 25, 2001 |
| Grant date | May 2, 2006 |
| Priority date | — |
| Expiry date | May 25, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for the identification of a modulator of the interaction between latency asssociated peptide (LAP) of transforming growth factor β1 (TGF-β1) and the integrin avb3, which method comprises: (a) providing, as a first component, LAP-β1 or a functional variant thereof (b) providing, as a second component, integrin avb3 or a functional variant thereof (c) contacting the two components with a test product under conditions that, in the absence of the test product, would permit the two components to interact; and (d) determining whether the test product is capable of modulating the interaction between the first and second components, thereby to determine whether the test product is a modulator of the interaction between LAP-β1 and integrin avb3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.